A monoclonal antibody being developed for the treatment of type 1 diabetes and other autoimmune diseases.
Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.
The numerical value of otelixizumab in Chaldean Numerology is: 1
The numerical value of otelixizumab in Pythagorean Numerology is: 4
Images & Illustrations of otelixizumab
Find a translation for the otelixizumab definition in other languages:
Select another language:
Discuss these otelixizumab definitions with the community:
Word of the Day
Would you like us to send you a FREE new word definition delivered to your inbox daily?
Use the citation below to add this definition to your bibliography:
"otelixizumab." Definitions.net. STANDS4 LLC, 2018. Web. 17 Feb. 2018. <https://www.definitions.net/definition/otelixizumab>.